Boxing coach with prostate cancer from ERLEADA® (apalutamide) commercial coaching student

I HAVE PROSTATE
CANCER AND

I’m up for
the fight.

Learn about 2 types of prostate cancer

Learn about mCSPC
Learn about nmCRPC

What is mCSPC?

Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone. This is called metastatic castration-sensitive prostate cancer or mCSPC.

The most common sites where prostate cancer can spread are bones, adrenal gland, liver, and lungs.

Talk to
Your Doctor

Learn more about ERLEADA^®

What is nmCRPC?

Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone. This is called non-metastatic castration-resistant prostate cancer or nmCRPC.

Prostate-speciﬁc antigen (PSA) is one of the ways your doctor may monitor your prostate cancer.

Often, PSA levels rise, which could be one of the indicators that the cancer may be progressing.